- Home
- Reports
- Healthcare IT
- Biohacking Market
Biohacking Market: Information by Type (Inside, Outside), Product (Smart Drugs, Sensors, Strains), Application (Synthetic, Genetic Engineering), End-user (Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others), Region - Global Forecast till 2028
ID: MRFR/HCIT/3719-CR | February 2021 | Region: Global | 157 pages
Market Synopsis
Biohacking Market is projected to reach USD 63 Billion by 2028, at a CAGR of 19% from 2021 to 2028. Biohacking refers to the use of function-enhancing drugs or the use of external or internal implants to improve cognitive function, memory, and creativity in individuals. The most prolific method include the intake of nootropic drugs to develop intelligence and focus. It is also known as do-it-yourself (DIY) biology. Biohackers have set up shop in warehouses, garages, and other such spaces. Some of the well-known labs in the U.S. include Biogarage, Bioartlab, Genspace, BioCurious, and LA Biohackers.
Awareness of biohacking, prevalence of chronic diseases, and demand for smart devices and drugs are factors likely to drive the market growth over the forecast period (2021-2028). Lack of cyber security practices can deter the market growth. The sharp rise noticed in chronic diseases coupled with the growing geriatric populace is expected to provide opportunities for the market to grow.
The increasing use of radiofrequency identification (RFID) technology in medical devices combined with the penetration of internet of things (IoT) in healthcare, fitness, and consumer electronics is expected to push the market demand. This can be credited to the need for quality healthcare needs among the populace.
Report Overview
The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts make highly astute projections regarding the scope of the market and its future prospects. MRFR’s report includes a thorough analysis of the global biohacking market segmented by type, product, application, end-user, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.
Segment Overview
By type, the global biohacking market is segmented into outside and inside biohacking. Product-wise, the market is segmented into strains, sensors, smart drugs, and others. Major applications include synthetic biology, forensic science, genetic engineering, diagnosis & treatment, drug testing, and others. End-users in the market include pharmaceutical & biotechnology companies, forensic laboratories, and others.
The segments covered in the biohacking market report are analyzed with respect to four major regions – Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA), with respective country-level market sizing. The report discusses in detail the various players residing in these regions and their respective strategies to climb up the market ladder.
Competitive Landscape
Noteworthy industry participants in the biohacking market include Thync Global Inc. (U.S.), Synbiota (Canada), Apple (U.S.), HVMN, Inc. (U.S.), MoodMetric (U.S.), THE ODIN (U.S.), and Fitbit, Inc. (U.S.). The report offers comprehensive profiles on these market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, expansion techniques, and latest R&D initiatives are discussed in minute detail.
Research Methodology
At MRFR, our research analysts conduct a thorough objective analysis of the market when creating market reports by adhering to a rigorous set of standards which allow a truly comprehensive view of the market. Use of primary research strategies such as interviews with top executives of biohacking kits and tools manufacturers. Secondary research entails a thorough analysis of past and present trends in a forward-looking manner. Additionally, market size estimation and validation use both top-down & bottom-up approaches to obtain data from the value and supply chain. The balanced number of buyers and suppliers will result in a negligible demand-supply gap. Credible resources are accessed and verified by analysts to understand the nuances of market factors with consistency. Competent data analysts use strong analytical tools to ascertain accurate analysis of very relevant parameters in an effort to provide clients with a conclusive and dependable view of the future.
Analysis Period
- Base Year - 2016
- Projection Period - From 2017 to 2023
- Market Denomination - USD Million
- Conversion Rate - Considered as per the respective financial years
For the scope of research, the report offers a comprehensive analysis of the global biohacking market.
Product
- Smart Drugs
- Sensors
- Strains
- Others
Application
- Synthetic Biology
- Genetic Engineering
- Forensic Science
- Diagnosis & Treatment
- Drug Testing
End-user
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Others
Region
- Americas
- The U.S.
- Canada
- South America
- Europe
- Germany
- France
- The U.K.
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- Republic of Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Qatar
- Kuwait
- Oman
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East & Africa
Intended Audience
- Government Research Laboratories
- Research and Development (R&D) Companies
- Private Research Laboratories
- Biopsy Devices Manufacturers
- Market Research and Consulting Service Providers
- Biopsy Devices Suppliers
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2028: USD 63 Billion |
| CAGR | 19% (2021-2028) |
| Base Year | 2020 |
| Forecast Period | 2021-2028 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Thync Global Inc. (U.S.), Synbiota (Canada), Apple (U.S.), HVMN, Inc. (U.S.), MoodMetric (U.S.), THE ODIN (U.S.), and Fitbit, Inc. (U.S.). |
| Key Market Opportunities | The sharp rise noticed in chronic diseases coupled with the growing geriatric populace |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The global biohacking market is estimated to grow to USD 63 Billion by 2028
The global biohacking market is projected to grow at approximately 19% CAGR during forecast period (2021-2028).
Increasing use of RFID technology in medical devices.
North America holds the largest share in the global biohacking market followed by Europe and Asia Pacific, respectively.
HVMN, Inc., ODIN, Synbiota, Thync Global Inc., Apple, Moodmetric, and Fitbit, Inc., others, are some of the major players operating in the biohacking market.
Biohacking Market – Summary
The healthcare sector is moving gradually towards customization of treatment. The cure for a particular disease depends mostly on individual biology and more the knowledge, more the chances for finding a better cure for various diseases. Many can consider biohacking or Do-it-Yourself (DIY) biology as avant-garde, but it’s the next leap that synthetic biology is making. The procedure includes constant monitoring of an individual’s biology with a blend of medical, nutritional, and electronic technique. The lab experiments are done in this process on a much smaller and focused scale to explore various possibilities associated with biotechnology, molecular biology, genetic engineering, and many other aspects. Among the different experimental techniques, inserting a microchip into the body to control the stress level or monitor heart rate has gained momentum.
Prevalence of chronic diseases, such as diabetes and cancer, is one major driving force that is triggering the market growth. As per the reports of the American Cancer Association, 13% of the population are often diagnosed with cancer before they cross age 20. The American Diabetic Association indicates that 9.3% of the entire population is suffering from diabetes. Such chronic diseases are always a burden on the country as they reduce productivity considerably. Early diagnosis is the only way out and is a belief that is triggering the biohacker market growth.
Advancing technologies have also infused the healthcare market with innovative medical devices and sensors, and the sector is growing by leaps and bounds. But its just the beginning as a constant influx of upgradation is also expected to create healthcare-related awareness and would widen the horizon of the market. Various technologies such as radio frequency identification (RFID) and the inclusion of the internet of things (IoT) have gained momentum in the sector. Their application in various gadgets has charmed a particular section of the populace which in consequence is propelling the market ahead in an unprecedented way.
On the flip side, the market can witness a perforating effect from cybercrimes. Web hackers’ invasion can leak confidential data which can have a detrimental impact on the market. At the same time, insulin pumps, cochlear implants, and pacemakers can be accessed remotely which could result in fatal consequences or divulge personal information. This can bottleneck the market for a short span of time. However, gadget-friendly generation can give the market a new direction.
Segmentation Analysis:
Type-wise segmentation includes outside and inside biohacking. Outside biohacking had a market valuation of USD 4,579.35 million in 2017 which is expecting almost quadruple rise during the forecast period to USD 16,142.38 million with the fastest CAGR of 19.72%. Inside biohacking is also gaining considerable ground and is touted to inflate with an 18.88% CAGR during the same period.
By product, the market can be segmented into smart drugs, sensors, strains, and others. Smart drug segment is spearheading the market, and its growth from a valuation of USD 3,367.33 million to a predicted USD 11,980.71 million in 2023 is impressive as it gives a peek into the biohacker market’s proliferation. The sub-segment is also going to have the fastest CAGR of 19.88% during the review period.
Based on applications, the market can be segmented into synthetic biology, genetic engineering, forensic science, diagnosis & treatment, drug testing, and others. Synthetic Biology to grow substantially and dominate the market during the assessment period by having a valuation of USD 3,255.75 million. The segment will also ensure a significant foothold with the maximum CAGR of 19.81% during the same period.
Based on end-users, the market can be segmented into pharmaceutical & biotechnology companies, forensic laboratories, and others. Pharmaceutical & biotechnology companies held the most significant share of the globally generated revenue in 2017, and during the forecast period, it can rise to a valuation of USD 13,882.08 million. An impressive CAGR of 19.73% will ensure the quadruple leap.
Regional Analysis:
Geographic analysis of the global market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas, with a market valuation of USD 2999.05 million, are currently the market deciders and an expected rise to USD 10573.53 million can ensure their position in the top. Presence of a large number of biotechnology and synthetic biology companies in the region can take the credit for the region’s supremacy. In addition, youth from the region are more aware of the far-fetching impacts of the market which acts as a tailwind for the market.
However, the APAC is not far behind in gaining momentum and can scale a CAGR of 19.91% during the same period. The region has a huge patient pool suffering from chronic diseases which are impacting the regional market in a significant way. Emerging economies such as India and China are also making remarkable efforts in revamping their medical infrastructure which can consequently boost the market.
Competitive Analysis:
Among the various fields, animal-free leather, electric DNA control, non-browning apples, DNA printing and other are segments that can bring in significant change in the biohacking market. The key players are investing heavily in developing strategies that would give them the advantage to stay ahead of the rest. These strategies often include mergers and acquisitions, along with innovations. The ODIN, at present, is leading the market with 25% of the total market share followed by HVMN, Inc., and Synbiota.
Major companies profiled in the report include ODIN, HVMN, Inc., Synbiota, Apple, Thync Global Inc., U.S.A., Moodmetric, Fitbit, Inc., and others.
1 Report Prologue
2 Market Introduction
2.1 Introduction 19
2.2 Scope Of Study 19
2.3 Research Objective 20
2.4 Assumptions & Limitations 20
2.4.1 Assumptions 20
2.4.2 Limitations 20
2.5 Market Structure 21
3 Research Methodology
3.1.1 Primary Research Methodology 23
3.1.2 Secondary Research Methodology 24
3.1.3 Market Share Analysis 25
3.1.4 Trade Analysis 25
3.2 Forecast Model 26
4 Market Dynamics
4.1 Introduction 27
4.2 Drivers 28
4.2.1 Rising Prevalence Of Chronic Disease (45%) 28
4.2.2 Growing Awareness About Biohacking (25%) 29
4.2.3 Increasing Demand For Innovative Medical Devices And Sensors (30%) 30
4.3 Restraints 31
4.3.1 Lack Of Cyber Security Practices 31
4.4 Opportunities 32
4.4.1 Technological Advancement 32
4.5 Mega Trends 32
4.5.1 Exploration Of Future Biohacking Products On Rise 32
4.6 Macroeconomic Indicators 33
5 Market Factor Analysis
5.1 Value Chain Analysis 34
5.1.1 Primary Activities 34
5.1.2 Secondary Activities 35
5.2 Porters Five Forces Model 36
5.2.1 Bargaining Power Of Suppliers 37
5.2.2 Bargaining Power Of Buyers 37
5.2.3 Threat Of New Entrants 37
5.2.4 Threat Of Substitutes 37
5.2.5 Intensity Of Rivalry 38
6 Global Biohacking Market, By Type
6.1 Introduction 39
6.2 Outside Biohacking 40
6.3 Inside Biohacking 40
7 Global Biohacking Market By Product
7.1 Introduction 41
7.2 Smart Drugs 42
7.3 Sensors 44
7.4 Strains 45
7.5 Others 46
8 Global Biohacking Market By Application
8.1 Introduction 47
8.2 Synthetic Biology 48
8.3 Genetic Engineering 49
8.4 Forensic Science 51
8.5 Diagnosis & Treatment 51
8.6 Drug Testing 53
8.7 Others 53
9 Global Biohacking Market, By End User
9.1 Introduction 54
9.2 Pharmaceutical & Biotechnology Companies 55
9.3 Forensic Laboratories 55
9.4 Others 56
10 Global Biohacking Market, By Region
10.1 Introduction 57
10.2 Americas 58
10.2.1 U.S. 63
10.2.2 Canada 65
10.2.3 South America 68
10.3 Europe 72
10.3.1 Germany 76
10.3.2 France 79
10.3.3 U.K 82
10.3.4 Italy 85
10.3.5 Spain 88
10.3.6 Rest Of Western Europe 91
10.3.7 Eastern Europe 94
10.4 Asia Pacific 98
10.4.1 Japan 103
10.4.2 China 105
10.4.3 India 108
10.4.4 Australia 111
10.4.5 Republic Of Korea 114
10.4.6 Rest Of Asia Pacific 117
10.5 Middle East & Africa 121
10.5.1 United Arab Emirates 125
10.5.2 Saudi Arabia 128
10.5.3 Oman 131
10.5.4 Kuwait 134
10.5.5 Qatar 137
10.5.6 Rest Of Middle East & Africa 140
11 Company Landscape
11.1 Introduction: Key Players 144
11.2 Company Share Analysis 144
12 Company Profile
12.1 Fitbit, Inc. 145
12.1.1 Company Overview 145
12.1.2 Financials 145
12.1.3 Products 145
12.1.4 Strategy 145
12.1.5 Key Developments 145
12.2 Apple 146
12.2.1 Company Overview 146
12.2.2 Financials 146
12.2.3 Products 146
12.2.4 Strategy 146
12.2.5 Key Developments 146
12.3 Synbiota 147
12.3.1 Company Overview 147
12.3.2 Financials 147
12.3.3 Products 147
12.3.4 Strategy 147
12.3.5 Key Developments 147
12.4 THE ODIN 148
12.4.1 Company Overview 148
12.4.2 Financials 148
12.4.3 Products 148
12.4.4 Strategy 148
12.4.5 Key Developments 148
12.5 HVMN, Inc. 149
12.5.1 Company Overview 149
12.5.2 Financials 149
12.5.3 Products 149
12.5.4 Strategy 149
12.5.5 Key Developments 149
12.6 Thync Global Inc., U.S.A. 150
12.6.1 Company Overview 150
12.6.2 Financials 150
12.6.3 Products 150
12.6.4 Strategy 150
12.6.5 Key Developments 150
12.7 MoodMetric 151
12.7.1 Company Overview 151
12.7.2 Financials 151
12.7.3 Products 151
12.7.4 Strategy 151
12.7.5 Key Developments 151
13 Conclusion
13.1 Key Findings 152
13.1.1 CEO’s Viewpoint 152
13.1.2 Unmet Needs 152
13.1.3 Key Companies To Watch 152
13.1.4 Prediction Of Biohacking Industry 152
14 Appendix
14.1 Discussion Blue Print 154
14.2 References 156
15 List Of Tables
TABLE 1 PRIMARY INTERVIEWS 23
TABLE 2 GLOBAL BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 39
TABLE 3 GLOBAL BIOHACKING MARKET FOR OUTSIDE BIOHACKING BY REGION, 2020 TO 2027 (USD MILLION) 40
TABLE 4 GLOBAL BIOHACKING MARKET FOR INSIDE BIOHAKCING, BY REGION, 2020 TO 2027 (USD MILLION) 40
TABLE 5 GLOBAL BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 41
TABLE 6 GLOBAL SMART DRUGS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 43
TABLE 7 GLOBAL SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 43
TABLE 8 GLOBAL SENSORS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 44
TABLE 9 GLOBAL STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 45
TABLE 10 GLOBAL STRAINS MARKET BY REGION, 2020 TO 2027 (USD MILLION) 45
TABLE 11 GLOBAL BIOHACKING MARKET BY OTHER PRODUCT, 2020 TO 2027 (USD MILLION) 46
TABLE 12 GLOBAL BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 47
TABLE 13 GLOBAL BIOHACKING MARKET FOR SYNTHETIC BIOLOGY, BY REGION, 2020 TO 2027 (USD MILLION) 49
TABLE 14 GLOBAL BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 50
TABLE 15 GLOBAL BIOHACKING MARKET FOR GENETIC ENGINEERING, BY REGION, 2020 TO 2027 (USD MILLION) 50
TABLE 16 GLOBAL BIOHACKING MARKET FOR FORENSIC SCIENCE, BY REGION, 2020 TO 2027 (USD MILLION) 51
TABLE 17 GLOBAL BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 52
TABLE 18 GLOBAL BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY REGION, 2020 TO 2027 (USD MILLION) 52
TABLE 19 GLOBAL BIOHACKING MARKET FOR DRUG TESTING, BY REGION, 2020 TO 2027 (USD MILLION) 53
TABLE 20 GLOBAL BIOHACKING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020 TO 2027 (USD MILLION) 53
TABLE 21 GLOBAL BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 54
TABLE 22 GLOBAL BIOHACKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES BY REGION, 2020 TO 2027 (USD MILLION) 55
TABLE 23 GLOBAL BIOHACKING MARKET FOR FORENSIC LABORATORIES BY REGION, 2020 TO 2027 (USD MILLION) 55
TABLE 24 GLOBAL BIOHACKING MARKET FOR OTHER END USERS BY REGION, 2020 TO 2027 (USD MILLION) 56
TABLE 25 GLOBAL BIOHACKING MARKET BY REGION, 2020 TO 2027 (USD MILLION) 57
TABLE 26 AMERICAS BIOHACKING MARKET BY REGION, 2020 TO 2027 (USD MILLION) 58
TABLE 27 NORTH AMERICA BIOHACKING MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 58
TABLE 28 AMERICAS BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 59
TABLE 29 AMERICAS BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 59
TABLE 30 AMERICAS SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 60
TABLE 31 AMERICAS STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 60
TABLE 32 AMERICAS BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 61
TABLE 33 AMERICAS BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 61
TABLE 34 AMERICAS BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 62
TABLE 35 AMERICAS BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 62
TABLE 36 U.S. BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 63
TABLE 37 U.S. BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 63
TABLE 38 U.S. SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 63
TABLE 39 U.S. STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 64
TABLE 40 U.S. BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 64
TABLE 41 U.S. BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 64
TABLE 42 U.S. BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 65
TABLE 43 U.S. BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 65
TABLE 44 CANADA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 65
TABLE 45 CANADA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 66
TABLE 46 CANADA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 66
TABLE 47 CANADA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 66
TABLE 48 CANADA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 67
TABLE 49 CANADA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 67
TABLE 50 CANADA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 68
TABLE 51 CANADA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 68
TABLE 52 SOUTH AMERICA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 68
TABLE 53 SOUTH AMERICA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 69
TABLE 54 SOUTH AMERICA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 69
TABLE 55 SOUTH AMERICA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 69
TABLE 56 SOUTH AMERICA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 70
TABLE 57 SOUTH AMERICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 70
TABLE 58 SOUTH AMERICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 71
TABLE 59 SOUTH AMERICA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 71
TABLE 60 EUROPE BIOHACKING MARKET BY REGION, 2020 TO 2027 (USD MILLION) 72
TABLE 61 WESTERN EUROPE BIOHACKING MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 73
TABLE 62 EUROPE BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 74
TABLE 63 EUROPE BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 74
TABLE 64 EUROPE SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 74
TABLE 65 EUROPE STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 75
TABLE 66 EUROPE BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 75
TABLE 67 EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 75
TABLE 68 EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 76
TABLE 69 EUROPE BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 76
TABLE 70 GERMANY BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 76
TABLE 71 GERMANY BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 77
TABLE 72 GERMANY SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 77
TABLE 73 GERMANY STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 77
TABLE 74 GERMANY BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 78
TABLE 75 GERMANY BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 78
TABLE 76 GERMANY BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 79
TABLE 77 GERMANY BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 79
TABLE 78 FRANCE BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 79
TABLE 79 FRANCE BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 80
TABLE 80 FRANCE SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 80
TABLE 81 FRANCE STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 80
TABLE 82 FRANCE BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 81
TABLE 83 FRANCE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 81
TABLE 84 FRANCE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 82
TABLE 85 FRANCE BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 82
TABLE 86 U.K BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 82
TABLE 87 U.K BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 83
TABLE 88 U.K SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 83
TABLE 89 U.K STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 83
TABLE 90 U.K BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 84
TABLE 91 U.K BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 84
TABLE 92 U.K BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 84
TABLE 93 U.K BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 85
TABLE 94 ITALY BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 85
TABLE 95 ITALY BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 85
TABLE 96 ITALY SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 86
TABLE 97 ITALY STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 86
TABLE 98 ITALY BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 87
TABLE 99 ITALY BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 87
TABLE 100 ITALY BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 88
TABLE 101 ITALY BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 88
TABLE 102 SPAIN BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 88
TABLE 103 SPAIN BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 89
TABLE 104 SPAIN SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 89
TABLE 105 SPAIN STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 89
TABLE 106 SPAIN BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 90
TABLE 107 SPAIN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 90
TABLE 108 SPAIN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 91
TABLE 109 SPAIN BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 91
TABLE 110 REST OF WESTERN EUROPE BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 91
TABLE 111 REST OF WESTERN EUROPE BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 92
TABLE 112 REST OF WESTERN EUROPE SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 92
TABLE 113 REST OF WESTERN EUROPE STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 92
TABLE 114 REST OF WESTERN EUROPE BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 93
TABLE 115 REST OF WESTERN EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 93
TABLE 116 REST OF WESTERN EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 94
TABLE 117 REST OF WESTERN EUROPE BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 94
TABLE 118 EASTERN EUROPE BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 94
TABLE 119 EASTERN EUROPE BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 95
TABLE 120 EASTERN EUROPE SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 95
TABLE 121 EASTERN EUROPE STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 95
TABLE 122 EASTERN EUROPE BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 96
TABLE 123 EASTERN EUROPE BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 96
TABLE 124 EASTERN EUROPE BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 97
TABLE 125 EASTERN EUROPE BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 97
TABLE 126 ASIA PACIFIC BIOHACKING MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 99
TABLE 127 ASIA PACIFIC BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 99
TABLE 128 ASIA PACIFIC BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 100
TABLE 129 ASIA PACIFIC SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 100
TABLE 130 ASIA PACIFIC STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 100
TABLE 131 ASIA PACIFIC BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 101
TABLE 132 ASIA PACIFIC BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 101
TABLE 133 ASIA PACIFIC BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 102
TABLE 134 ASIA PACIFIC BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 102
TABLE 135 JAPAN BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 103
TABLE 136 JAPAN BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 103
TABLE 137 JAPAN SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 103
TABLE 138 JAPAN STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 104
TABLE 139 JAPAN BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 104
TABLE 140 JAPAN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 104
TABLE 141 JAPAN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 105
TABLE 142 JAPAN BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 105
TABLE 143 CHINA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 105
TABLE 144 CHINA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 106
TABLE 145 CHINA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 106
TABLE 146 CHINA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 106
TABLE 147 CHINA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 107
TABLE 148 CHINA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 107
TABLE 149 CHINA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 108
TABLE 150 CHINA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 108
TABLE 151 INDIA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 108
TABLE 152 INDIA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 109
TABLE 153 INDIA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 109
TABLE 154 INDIA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 109
TABLE 155 INDIA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 110
TABLE 156 INDIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 110
TABLE 157 INDIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 111
TABLE 158 INDIA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 111
TABLE 159 AUSTRALIA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 111
TABLE 160 AUSTRALIA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 112
TABLE 161 AUSTRALIA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 112
TABLE 162 AUSTRALIA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 112
TABLE 163 AUSTRALIA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 113
TABLE 164 AUSTRALIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 113
TABLE 165 AUSTRALIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 114
TABLE 166 AUSTRALIA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 114
TABLE 167 REPUBLIC OF KOREA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 114
TABLE 168 REPUBLIC OF KOREA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 115
TABLE 169 REPUBLIC OF KOREA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 115
TABLE 170 REPUBLIC OF KOREA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 115
TABLE 171 REPUBLIC OF KOREA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 116
TABLE 172 REPUBLIC OF KOREA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 116
TABLE 173 REPUBLIC OF KOREA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 117
TABLE 174 REPUBLIC OF KOREA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 117
TABLE 175 REST OF ASIA PACIFIC BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 117
TABLE 176 REST OF ASIA PACIFIC BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 118
TABLE 177 REST OF ASIA PACIFIC SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 118
TABLE 178 REST OF ASIA PACIFIC STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 118
TABLE 179 REST OF ASIA PACIFIC BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 119
TABLE 180 REST OF ASIA PACIFIC BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 119
TABLE 181 REST OF ASIA PACIFIC BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 120
TABLE 182 REST OF ASIA PACIFIC BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 120
TABLE 183 MIDDLE EAST & AFRICA BIOHACKING MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 121
TABLE 184 MIDDLE EAST & AFRICA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 122
TABLE 185 MIDDLE EAST & AFRICA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 122
TABLE 186 MIDDLE EAST & AFRICA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 123
TABLE 187 MIDDLE EAST & AFRICA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 123
TABLE 188 MIDDLE EAST & AFRICA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 124
TABLE 189 MIDDLE EAST & AFRICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 124
TABLE 190 MIDDLE EAST & AFRICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 125
TABLE 191 MIDDLE EAST & AFRICA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 125
TABLE 192 UNITED ARAB EMIRATES BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 125
TABLE 193 UNITED ARAB EMIRATES BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 126
TABLE 194 UNITED ARAB EMIRATES SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 126
TABLE 195 UNITED ARAB EMIRATES STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 126
TABLE 196 UNITED ARAB EMIRATES BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 127
TABLE 197 UNITED ARAB EMIRATES BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 127
TABLE 198 UNITED ARAB EMIRATES BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 128
TABLE 199 UNITED ARAB EMIRATES BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 128
TABLE 200 SAUDI ARABIA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 128
TABLE 201 SAUDI ARABIA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 129
TABLE 202 SAUDI ARABIA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 129
TABLE 203 SAUDI ARABIA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 129
TABLE 204 SAUDI ARABIA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 130
TABLE 205 SAUDI ARABIA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 130
TABLE 206 SAUDI ARABIA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 131
TABLE 207 SAUDI ARABIA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 131
TABLE 208 OMAN BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 131
TABLE 209 OMAN BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 132
TABLE 210 OMAN SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 132
TABLE 211 OMAN STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 132
TABLE 212 OMAN BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 133
TABLE 213 OMAN BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 133
TABLE 214 OMAN BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 134
TABLE 215 OMAN BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 134
TABLE 216 KUWAIT BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 134
TABLE 217 KUWAIT BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 135
TABLE 218 KUWAIT SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 135
TABLE 219 KUWAIT STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 135
TABLE 220 KUWAIT BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 136
TABLE 221 KUWAIT BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 136
TABLE 222 KUWAIT BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 137
TABLE 223 KUWAIT BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 137
TABLE 224 QATAR BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 137
TABLE 225 QATAR BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 138
TABLE 226 QATAR SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 138
TABLE 227 QATAR STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 138
TABLE 228 QATAR BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 139
TABLE 229 QATAR BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 139
TABLE 230 QATAR BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 140
TABLE 231 QATAR BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 140
TABLE 232 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 140
TABLE 233 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY PRODUCT, 2020 TO 2027 (USD MILLION) 141
TABLE 234 REST OF MIDDLE EAST & AFRICA SENSORS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 141
TABLE 235 REST OF MIDDLE EAST & AFRICA STRAINS MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 141
TABLE 236 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 142
TABLE 237 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2020 TO 2027 (USD MILLION) 142
TABLE 238 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET FOR DIAGNOSIS & TREATMENT, BY TYPE, 2020 TO 2027 (USD MILLION) 143
TABLE 239 REST OF MIDDLE EAST & AFRICA BIOHACKING MARKET BY END USER, 2020 TO 2027 (USD MILLION) 143
16 List Of Figures
FIGURE 1 GLOBAL BIOHACKING MARKET, BY TYPE, 2020 (%) 15
FIGURE 2 GLOBAL BIOHACKING MARKET, BY PRODUCT, 2020 (%) 16
FIGURE 3 GLOBAL BIOHACKING MARKET, BY APPLICATION, 2020 (%) 16
FIGURE 4 GLOBAL BIOHACKING MARKET, BY END USER, 2020 (%) 17
FIGURE 5 GLOBAL BIOHACKING MARKET, BY REGION, 2020 (%) 18
FIGURE 6 GLOBAL BIOHACKING MARKET: MARKET STRUCTURE 21
FIGURE 7 RESEARCH METHODOLOGY 22
FIGURE 8 GLOBAL BIOHACKING MARKET: FORECAST MODEL 26
FIGURE 9 DROT ANALYSIS OF GLOBAL BIOHACKING MARKET 27
FIGURE 10 GLOBAL BIOHACKING MARKET: VALUE CHAIN 35
FIGURE 11 PORTERS FIVE FORCE MODEL: GLOBAL BIOHACKING MARKET 36
FIGURE 12 GLOBAL BIOHACKING MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 39
FIGURE 13 GLOBAL BIOHACKING MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 42
FIGURE 14 GLOBAL BIOHACKING MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 48
FIGURE 15 GLOBAL BIOHACKING MARKET, BY END USER, 2020 & 2027 (USD MILLION) 54
FIGURE 16 GLOBAL BIOHACKING MARKET, BY END USER, 2020 & 2027 (USD MILLION) 57
FIGURE 17 AMERICAS BIOHACKING MARKET, BY REGION, 2020 (%) 59
FIGURE 18 EUROPE BIOHACKING MARKET, BY REGION, 2020 (%) 73
FIGURE 19 ASIA PACIFIC BIOHACKING MARKET, BY COUNTRY, 2020 (%) 99
FIGURE 20 MIDDLE EAST & AFRICA BIOHACKIING MARKET, BY COUNTRY, 2020 (%) 122
FIGURE 21 COMPANY SHARE ANALYSIS: 2020 (%) 144
Market Overview:
Biohacking Market demographics include biological experiments that are done in small-sized labs either on the individual level or by a small community of people. This is one of the prominent reasons, why the Global Biohacking Market is popular as Do-It-Yourself or DIYs. Many garage labs are known to conduct biological functions and thus, making use of the drugs for functional enhancements. These enhancements are for both the internal, as well as internal implants. The main aim behind this the provision of cognitive functioning, better memory, and retention power, along with increasing creativity amongst individuals.
The prevalent biohackers in the Global Biohacking Market Report, are initiating the use of such services by opening up their shops in different locations like warehouses, and garages. The market experiments that can be performed in these shops are related to the use of light-sensitive bacteria for 3D printing, genetic engineering, and much more. The Biohacking Industry is expected to grow at a CAGR of 19% during the forecast period of 2021 to 2028.
COVID19 Analysis:
The coronavirus disease was nothing less than a shocking wave that has left some industries to go weak in the knees. The medical, healthcare and pharmaceutical industry witnessed a growing demand in its production and management lane in comparison to the other industries like construction, entertainment, and various other businesses.
Owing to the push provided by the global spread of coronavirus to the pharmaceutical industry, many key players of the market are undergoing activities related to research and development. The main agenda behind this is the development of a suitable drug beneficial for humankind, that helps in controlling the spread of the virus. Various government of dominant players in the biohacking industry is increasing their investments in such industries, so that, it is possible for companies to come up with viable and potable drugs to limit and gradually eradicate the virus.
Market Dynamics of Biohacking Market Research:
Drivers:
The biohackers are in the midway of developing and processing different products that can survey the human body along with the mind as a whole. Microchips and smart drugs, the developments are inclusive of the RFID implants and brain sensors, magnetic fingerprints and the stains of yeast and bacteria, monitoring the blood pressure levels, and tracking individual health. Owing to the need of bringing aesthetic changes, the technology being implemented is first being used on the biohackers’ body.
Restraints:
Biohacking technology is exposed to various risks like the lack of practices related to cybersecurity and its expertise. Also, there is an implication of several government regulations that are governing the experiments of genetic engineering. These are major restraints during the projected the year of 2023 for the market growth. Also, the market is experiencing a delay, and lack, of collecting the funds to support the wide-scale research and development.
Opportunities:
Owing to the Market Trends, there has been a fine spread in the increase for the RFID technology. RFID stands for radiofrequency identification. The use is being extended to the medical devices that are present in a combination with IoT penetration in different areas like health, wellness, and fitness, along with the healthcare sector. The consumer electronics sector is also a part of this. These factors can well enjoy the credit for creating the growth opportunities for the top biohacking products in the forecast period of 2017-2023.
Value Chain Analysis:
The emergence of the coronavirus crisis has pushed the need for wide operations of the pharma companies. Hence, activities for development and research to get to a viable solution in helping the masses are on the way. The activities that are being conducted are mostly likely to fuel different growth opportunities for the market on a global scale. Also, biohacking is emerging as a major market trend and people are spreading awareness regarding the same along with its connection with curing chronic diseases.
CVRx is one prominent market player that deals in the production of implants for treatment in cases of heart failure. Another player - Setpoint, is on the way to developing the neuro devices that are likely to aid the treatment for problems like Crohn’s disease, as well as arthritis. All these services are adding to the supply chain management to the end-users, by the efforts of the biohackers.
Segment Overview:
The top biohacking products belong to various segments of the Biohacking Market. These segments are as follows:
Type:
The market has both insides, as well as, outside biohacking, operated by the biohackers.
Product-Wise:
Owing to the need and bifurcation, the market includes sensors and strains, smart drugs, and much more.
Application:
The market segment of the application comes inclusive of drug testing - treatment and diagnosis, forensic sciences, synthetic biology, and genetic engineering, amongst others.
End-Users:
The End-Users are the first-hand users of the biohacking market and include forensic laboratories, pharma companies, and biotechnological industries.
Regions:
There are 4 major geographical locations, based on which, the Biohacking Report has been compiled. These are:
- North America
- APAC - Asia Pacific
- Europe, and
- MEA - the Middle East and Africa
Regional Analysis:
The Regional Analysis of the Biohacking Market consists of other regions like Latin America, the USA, and Canada as parts of the North American regions. Owing to the 2023 forecast year, the North American regions have the highest potential and expectation for growth, with prominent figures.
Many Key Players have their strategic presence in these parts of North America. For instance, some prevalent labs belonging to the US are LA Biohackers, Genspcae, Biogarage, BioCurious, as well as Bioartlab. These regional forces are making use of the most prolific methods for the development of nootropic drugs that are a result of intelligence, and biohackers’ focus.
Biohacking Market Research Competitive Landscape:
The Biohacking Market Size is prominent all around the globe. Some of the noteworthy players in the market are mentioned henceforth:
- Fitbit Inc. (US)
- Apple (US)
- HVMN Inc (US)
- The Odin (US)
- Thync Global Inc (US)
- Synbiota (Canada)
- MoodMetric (US)
These Market Players are not only accessing their company history, current market share, annual turnovers, and profit margins, but are also, focusing on the share generated by different segments, SWOT analysis, and strategies for growth and expansion. The latest push is in the form of innovation, and government investment for R&D-related initiatives.
Recent Developments:
Salvia Bioelectronics is a startup belonging to the Dutch region, that is on its way to the development of neurostimulation implantable devices. This has an important role to play in stopping migraine issues. The funds collected have reached an amount of 1.8 million euros, by the end of 2019.
Many startups are belonging to the US namely CVRx is known to have raised USD 340.6 million along with Setpoint that has a figure of USD 84.3 million, by developing the devices for neuro and heart devices. The Grindhouse wetware founder - Tim Cannon has known to have implanted a circadian device in his arm. This is body implantation that is first of its kind. The circadian device works well for the monitoring of body temperature.
Biohacking Market Overview:
Global Biohacking Market Research Report discusses all the major emerging market trends that reflect their impact on the market in the form of predictions and projections. The historical data in collaboration with the market dynamics, and forecasts regarding the market scope shortly, along with the prospects are covered. The report also consists of the Biohacking’s Market Segments and their sub-divisions. Also, the opportunities, prevailing, and emerging trends have been in limelight in collaboration with the share of particular regions, and the companies belonging to these regions. In all, the emphasis for the analysis is laid on different sources of generating the required revenue to meet the projected growth by the end of the forecast period of 2023.